Browse studies

Find your next paid study

3,226 recruiting studies matching your filters

Impacting Quality of Life and Pancreatic Cancer Survivorship Through a Telehealth Intervention

This clinical trial evaluates the impact of telehealth self-management coaching sessions on quality of life in pancreatic cancer survivors and their family car…

Metastatic Pancreatic Adenocarcinoma

Estimated

~$10 – $750

Actual pay is set by the research site.

City of Hope Medical CenterNCT06524973

Phase 2

The Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) Intervention: A Randomized Controlled Trial for Adolescents With Sickle Cell Disease to Prepare for Transition of Care

Randomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-R…

Sickle Cell DiseaseCognitive ImpairmentAdolescent Behavior+3 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of Alabama at BirminghamNCT05336201

Observational

Implementing Depression and Adherence Treatment in South Africa HIV Care

The goal of this clinical trial is to compare a core set and enhanced set of implementation strategies in increasing the reach of evidence-based treatments to …

DepressionHIVAdherence, Treatment+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MiamiNCT07032363

Phase 2

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-002 in Adult Participants With Moderate-to-Severe Hidradenitis Suppurativa

This is a multicenter, randomized, double-blinded, placebo-controlled clinical study of ORKA-002 in adult participants with moderate-to-severe HS.

Hidradenitis Suppurativa (HS)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Oruka Therapeutics, Inc.NCT07783542

Follow-Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

Background: The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from participants' tumor or from their blood, gr…

MelanomaAdenocarcinomaCarcinoma NOS+1 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT00923026

Phase 2

Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants With Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study

This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamo…

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more

Phase 1

A Pilot Study for Detection of PSMA-Low Castration Resistant and Neuroendocrine Prostate Cancer With 18F-fluciclovine PET/CT Imaging

This research study is studying a positron emission tomography (PET) agent called 18F-fluciclovine to evaluate how well 18F-fluciclovine-PET scans determine th…

Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Brigham and Women's HospitalNCT06062745

Apheresis and CD34+ Selection of Mobilized Peripheral Blood CD34+ Cells From Patients With DOCK8 Deficiency, LAD-1, and GATA2 Deficiency

Background: \- Gene therapy is being investigated as a possible treatment for individuals with immunodeficiency diseases or other conditions that make it diff…

LAD-1DOCK8GATA2 Deficancy

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT01212055

Observational

A Clinician-Patient Dual Behavior Change Framework to Leverage Informed Digital Nudges to Reduce Hospital Readmissions and Improve Patient Outcomes: A Randomized Trial for Scalable Strategy to Reduce Readmissions (PREVENT-R)

The PREVENT-R trial will evaluate an intervention targeting both clinician and patient behavior. The clinician-focused piece consists of an electronic medical …

ReadmissionReadmission RatesReadmission, Hospital+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Yale UniversityNCT07890961

Phase 1

A Phase 1/2 Study to Evaluate STK-012 as a Single Agent and in Combination Therapy in Subjects With Front-line Advanced NSCLC and Other Selected Indications

This is a phase 1/2, multicenter, open-label study. The phase 1 portion is a dose escalation and expansion study of STK-012 as monotherapy and in combination t…

Advanced Solid TumorNon Small Cell Lung CancerUntreated Advanced NSCLC+1 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

SynthekineNCT05098132

Observational

Electromagnetic Tracking of Devices During Interventional Procedures

This study will evaluate the accuracy and effectiveness of an experimental tracking device for locating abnormalities during invasive procedures, such as biops…

AdenocarcinomaProstate NeoplasmsProstate Cancer+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institutes of Health Clinical Center (CC)NCT00102544

Phase 1

Phase I Trial of ATR Inhibitor Camonsertib Combined With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

This phase I trial tests the safety, side effects, and best dose of camonsertib in combination with stereotactic body radiation therapy in controlling disease …

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell Carcinoma+27 more